Correlation Between Denali Therapeutics and Traws Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Traws Pharma, you can compare the effects of market volatilities on Denali Therapeutics and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Traws Pharma.

Diversification Opportunities for Denali Therapeutics and Traws Pharma

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Denali and Traws is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Traws Pharma go up and down completely randomly.

Pair Corralation between Denali Therapeutics and Traws Pharma

Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Traws Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 2.01 times less risky than Traws Pharma. The stock trades about -0.21 of its potential returns per unit of risk. The Traws Pharma is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  446.00  in Traws Pharma on September 23, 2024 and sell it today you would earn a total of  56.00  from holding Traws Pharma or generate 12.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Denali Therapeutics  vs.  Traws Pharma

 Performance 
       Timeline  
Denali Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Traws Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Traws Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Denali Therapeutics and Traws Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Denali Therapeutics and Traws Pharma

The main advantage of trading using opposite Denali Therapeutics and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.
The idea behind Denali Therapeutics and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges